Are you Dr. Turcotte?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Rockville Pike
# Crc
Bethesda, MD 20892Phone+1 301-496-1211
Summary
- Dr. Simon Turcotte, MD is a general surgeon in Bethesda, Maryland. He is currently licensed to practice medicine in District of Columbia.
Education & Training
- University of Montreal Faculty of MedicineClass of 2003
Certifications & Licensure
- DC State Medical License 2009 - 2013
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 4 citationsRadiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases.Ralph Saber, David Henault, Nouredin Messaoudi, Rolando Rebolledo, Emmanuel Montagnon
Journal of Translational Medicine. 2023-07-27 - 7 citationsMHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment.Brian D Griffith, Simon Turcotte, Jenny Lazarus, Fatima Lima, Samantha Bell
Cancers. 2022-08-24 - 5 citationsEffect of intraoperative hypovolemic phlebotomy on transfusion and clinical outcomes in patients undergoing hepatectomy: a retrospective cohort studyMaher Al Khaldi, Filip Gryspeerdt, François Martin Carrier, Claudia Bouchard, Eve Simoneau
Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie. 2021-05-04
Press Mentions
- Haystack Oncology and Université De Montréal’s Affiliated Hospital Research Centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal CancerJuly 29th, 2024
- Haystack Oncology and Université De Montréal's Affiliated Hospital Research Centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal CancerJuly 29th, 2024
- Turnstone Biologics Announces TIL Therapy Research Collaboration with the University of Montreal Hospital Research CentreApril 25th, 2022
- Join now to see all
Professional Memberships
- Member